Cargando…
COVID-19 Biomarkers in research: Extension of the OncoMX cancer biomarker data model to capture biomarker data from other diseases.
Scientists, medical researchers, and health care workers have mobilized worldwide in response to the outbreak of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; SCoV2). Preliminary data have captured a wide range of host responses, symptoms, and lingering problems po...
Autores principales: | Gogate, N, Lyman, D, Crandall, K.A, Kahsay, R, Natale, D.A, Sen, S, Mazumder, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491515/ https://www.ncbi.nlm.nih.gov/pubmed/32935101 http://dx.doi.org/10.1101/2020.09.09.196220 |
Ejemplares similares
-
OncoMX: A Knowledgebase for Exploring Cancer Biomarkers in the Context of Related Cancer and Healthy Data
por: Dingerdissen, Hayley M., et al.
Publicado: (2020) -
COVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data model
por: Gogate, Nikhita, et al.
Publicado: (2021) -
Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers
por: Acebes-Fernández, Vanessa, et al.
Publicado: (2020) -
Dreamweaver MX extensions
por: Gutman, Laura
Publicado: (2002) -
Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)